Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $12.94 USD
Change Today +0.16 / 1.25%
Volume 25.1K
DPRX On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 06/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert J. DeLuccia

Co-Founder and Executive Chairman, Dipexium Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 2 different organizations across 5 different industries.

See Board Relationships
68$2,029,036
As of Fiscal Year 2014

Background*

Mr. Robert J. DeLuccia co-founded Dipexium Pharmaceuticals, Inc. in 2010 and served as its Managing Partner from January 2010 to March 2014. Mr. DeLuccia is a life sciences executive with over 35 years pharmaceutical industry experience with both public and private international pharmaceutical companies and development stage biopharmaceutical companies. He served as the President and Chief Executive Officer of MacroChem Corporation from June 19, 2003 to April 2008. He ...

Read Full Background

Corporate Headquarters*

61 Broadway
New York, New York 10006

United States

Phone: 212-269-2834
Fax: 212-269-2580

Board Members Memberships*

Former Director
Co-Founder and Executive Chairman
2000-Present
Lead Director, Chairman of Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee
2000-N/A
Chairman and Chairman of Virium Pharmaceuticals Inc

Education*

BS
Iona College
MBA
Iona College

Other Affiliations*

Annual Compensation*

Salary$364,247
Total Annual Compensation$364,247

Stock Options*

All Other Compensation$92,964
Exercisable Options74,707
Unexercisable Options224,120
Total Number of Options298,827

Total Compensation*

Total Annual Cash Compensation$457,211
Total Short Term Compensation$364,247
Other Long Term Compensation$92,964
Total Calculated Compensation$2,029,036
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DPRX:US $12.94 USD +0.16

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DIPEXIUM PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.